WASHINGTON, June 27 (Reuters) - The U.S. Supreme Court on Monday agreed to weigh in on whether genetic-testing kits made by biotechnology company Life Technologies Corp infringed upon patents held by Promega Corp.
The court will review a December 2014 ruling by the U.S. Court of Appeals for the Federal Circuit that tossed out some of Promega’s claims while upholding others. (Reporting by Lawrence Hurley; Editing by Will Dunham)
Our Standards: The Thomson Reuters Trust Principles.